HOME >> MEDICINE >> NEWS
Resistance to anti-flu agents increasing worldwide

Worldwide resistance to drugs used to treat influenza has increased by 12% since the mid-nineties, concludes a report published online today (Thursday September 21, 2005) by THE LANCET.

Adamantanes have been used to treat influenza A virus infections for more than 30 years. Previous surveillance studies have identified a low incidence of resistance to amantadine and rimantadine among circulating influenza virus strains. However, it has been 10 years since the last comprehensive global study of resistance to these drugs was published.

In the largest study of adamantane resistance to date, Rick Bright (Centers for Disease Control and Prevention, Atlanta, GA, USA) and colleagues screened 7000 influenza A isolates for gene mutations known to confer drug resistance. They found that drug resistance increased from 0.4% in 1994-1995 to 12.3% in 2003-2004. They also found that 61% of resistant viruses isolated since 2003 were from people in Asia. Some Asian countries had drug resistance frequencies exceeding 70%.

Dr Bright comments: "We were alarmed to find such a dramatic increase in drug resistance in circulating human influenza viruses in recent years. Our report has broad implications for agencies and governments planning to stockpile these drugs for epidemic and pandemic strains of influenzaWith the increasing rates of resistance shown here, amantadine and rimantadine will probably no longer be effective for treatment or prophylaxis in the event of a pandemic outbreak of influenza." (Quote by e-mail; does not appear in published paper)


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
21-Sep-2005


Page: 1

Related medicine news :

1. Cranberries contain possible anti-caries/anti-plaque agents
2. New contrast agents may be on horizon for better medical imaging
3. New infectious agents pose new risks for people with bleeding disorders, Jefferson hematologist says
4. Use of gastric acid-suppressive agents linked with increased risk for diarrhea infection
5. Program may improve physicians knowledge about diseases caused by bioterrorism agents
6. Gadonanotubes greatly outperform existing MRI contrast agents
7. Possible exposure to nerve agents and brain cancer deaths in Gulf War veterans
8. Herbal medicine may alter cell response to cancer therapeutic agents
9. Penn researchers discover novel pathway for increasing good cholesterol
10. Drugs users are increasingly more cautious with needles
11. Home improvement warning -- Ladder-related injuries increasing in the US

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology:
Cached News: